Search the Newsreel

William Blair Downgrades Cardiff Oncology to Market Perform From Outperform

William Blair has downgraded Cardiff Oncology (CRDF) from an "Outperform" rating to "Market Perform." This comes shortly after Cardiff Oncology reported its earnings results for the second quarter and six months ended June 30, 2026. The company is a clinical-stage biotechnology firm focused on …

Cardinal Infrastructure Group (CDNL) doubles revenue as assets top $1B in 2026

Handelsbanken Fonder AB Acquires 14,919 Shares of Cardinal Health, Inc. $CAH

Handelsbanken Fonder AB increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 12.5% in the second quarter, acquiring an additional 14,919 shares. This move is part of broader institutional investor activity in Cardinal Health, which has recently seen positive news including an earnings beat, …

Visa and Mastercard Have Both Reported. Which Payments Giant Is the Best Buy Now?

Key Points Both companies posted a 14% year-over-year revenue gain during the three-month period that ended June 30. Mastercard's operating income has risen at a much faster clip in the past five years. The best investment opportunity between these two stocks trades at a …

Will Cardiol Therapeutics Inc Class A (CRDL) Beat Estimates Again in Its Next Earnings Report?

William Blair downgrades Cardiff Oncology stock rating on rights uncertainty

William Blair has downgraded Cardiff Oncology (NASDAQ: CRDF) from Outperform to Market Perform, citing material deterioration in company fundamentals and uncertainty surrounding onvansertib rights. This downgrade follows Cardiff’s Q2 financial results and business update, with the stock already down 63% year-to-date and the company …

Cardinal Health (NYSE:CAH) Sets New 52-Week High After Earnings Beat

Cardinal Health (CAH) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.42 per share. This compares to earnings of $2.08 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market

Cardinal Health's stock jumped nearly 7% after reporting better-than-expected fourth-quarter earnings and issuing an upbeat fiscal 2027 outlook. The company's CEO highlighted its growing position in cell and gene therapies, now exclusively serving nearly half of that market. Cardinal Health also expanded its share …

Cardinal Health (CAH) Stock Richly Valued Despite $5b Cash Flow Strength

Cardiol Therapeutics at Canaccord Genuity: Phase III catalyst nears By Investing.com

Cardiol Therapeutics is nearing a crucial Phase III readout for its lead drug, CardiolRx, in recurrent pericarditis. The company presented its clinical and commercial strategy at Canaccord Genuity's 46th Annual Growth Conference, highlighting the drug's potential, market opportunity, and positive payer feedback. Despite the …

Cardinal Infrastructure Group Inc. (CDNL) Investigation

Hagens Berman is investigating Cardinal Infrastructure Group Inc. (CDNL) following a significant drop in its stock price after the company reported severe profit margin compression in its Q2 2026 financial results. The investigation focuses on whether Cardinal failed to disclose critical cost pressures and …

CPI Card Group raises price target after beating earnings and boosting revenue.

CPI Card Group reported strong Q2 earnings, surpassing EPS estimates and achieving a 15% revenue increase, largely driven by its Secure Card Solutions segment and the Arroweye acquisition. The company recorded a record $36 million in first-half free cash flow, leading Roth Capital to …

Cardiff Oncology (NASDAQ: CRDF) cuts R&D spend but flags going concern risk

Cardiff Oncology reported a Q2 2026 net loss of $9.2 million and a six-month operating cash outflow of $24.1 million, reducing R&D expenses by cutting clinical trials and preclinical work. The company raised $10.1 million in a direct offering but issued a "going concern" …

Cardiff Oncology earnings missed by $0.02, revenue topped estimates

Cardinal Health Inc (CAH) (Q4 2026) Earnings Call Highlights: Record EPS Growth and Robust ...

This article first appeared on GuruFocus. Revenue: Total company revenue for Q4 fiscal 2026 was $63.7 billion, an increase of 6% year-over-year. Gross Profit: Gross profit grew 16% to $2.6 billion in the quarter. Operating Income: Enterprise operating income was $935 million, up 30% …

Cardiff Oncology: Q2 Earnings Snapshot

Cardiff Oncology, Inc. (CRDF) reported a Q2 loss of $9.2 million, or 14 cents per share, surpassing Wall Street expectations that predicted a loss of 17 cents per share. The company achieved revenue of $104,000, which met Street forecasts. This financial summary was generated …

Cardiff Oncology (NASDAQ:CRDF) Releases Earnings Results, Misses Expectations By $0.02 EPS

Cardiff Oncology (NASDAQ:CRDF) reported a quarterly loss of $0.14 per share, missing analyst expectations by $0.02, despite revenue of $0.10 million surpassing the consensus estimate. The company's shares are trading under pressure, well below moving averages, and analysts generally hold a "Hold" rating. Despite …

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Cardiff Oncology announced its second quarter 2026 financial results and provided a business update, highlighting positive Phase 2 data for its drug onvansertib in first-line RAS-mutated metastatic colorectal cancer. The company plans to initiate a registrational Phase 3 trial in Q1 2027, pending additional …

Earnings To Watch: Cardinal Health (CAH) Reports Q2 Results Tomorrow

Earnings To Watch: Cardinal Health (CAH) Reports Q2 Results Tomorrow Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday before market hours. Here's what to expect. Cardinal Health missed analysts' revenue expectations last quarter, reporting revenues of $60.94 …

Cardinal Health Bolts Higher Despite Mixed Earnings. Here's Why.

Cardinal Health stock jumped Tuesday after the medical wholesaler's fiscal 2027 guidance handily beat Wall Street's expectations. Continue Reading

Mastercard Stock Rises as Services Revenue Jumps 20%

This article first appeared on GuruFocus. Mastercard (NYSE:MA), the global payments powerhouse connecting banks, merchants and consumers, rose approximately 0.6% in Tuesday's regular-session trading as another strong quarter showed just how much horsepower remains in the business. Second-quarter net revenue jumped 14% to $9.3 …

Cardinal Infrastructure Group Inc. Class A Common Stock Q2 2026 Earnings Call Summary

Cardinal Infrastructure Group Inc. Class A Common Stock Q2 2026 Earnings Call Summary - Moby Strategic Execution and Performance Attribution Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why …

Cardinal Health, Inc. Q4 2026 Earnings Call Summary

Cardinal Health, Inc. Q4 2026 Earnings Call Summary - Moby Strategic Performance and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

Cardinal Health Q4 Earnings Call Highlights

Key Points Interested in Cardinal Health, Inc.? Here are five stocks we like better. Cardinal Health delivered strong fiscal fourth-quarter results: Revenue rose 6% to $63.7 billion, operating income increased 30% to $935 million, and adjusted EPS climbed 40% to $2.91. Results included a …

Why Cardinal Infrastructure Group Stock Just Crashed

Cardinal Infrastructure Group (NASDAQ: CDNL) stock is getting crushed in Tuesday's trading. Shares were down 25.7% as of 11:30 a.m. ET despite relatively little movement for the broader market. Cardinal published its second-quarter report before the market opened this morning, publishing mixed results that …

Cardinal Infrastructure Group Q2 Earnings Call Highlights

Key Points Interested in Cardinal Infrastructure Group Inc.? Here are five stocks we like better. Record growth lifted the outlook: Second-quarter revenue surged 114% year over year to $227 million, including 56% organic growth, while backlog reached $866 million. Cardinal raised 2026 revenue guidance …

Cardinal Infrastructure Group Q2 2026 Earnings Call Transcript

Cardinal Infrastructure Group Inc. Class A Common Stock Q2 2026 Earnings Call Summary - Moby Strategic Execution and Performance Attribution Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why …

MicroPort CardioFlow Signals Revenue Surge as CRM Acquisition Fuels Global Growth

Cardinal Health Bolts Out Of A Buy Zone Despite Mixed Earnings. Here's Why.

Cardinal Health stock jumped Tuesday after the medical wholesaler's fiscal 2027 guidance handily beat Wall Street's expectations. Continue Reading

Cardinal Infrastructure Group Releases Q2 2026 Earnings and Investor Materials

Cardinal Infrastructure Group Inc. announced its Q2 2026 financial results and supplemental investor materials via an 8-K filing on August 11, 2026. The company, an emerging growth entity, provided a press release and investor presentation detailing its performance for the quarter ended June 30, …

Cardinal Infrastructure Q2 EPS misses estimate despite revenue beat

Cardinal Infrastructure Group reported Q2 2026 EPS of $0.26, missing the analyst consensus of $0.46, despite revenue reaching $226.9 million, significantly beating the $176.1 million estimate. The company's revenue surge was driven by 64% organic growth and recent acquisitions, including Allied Paving Contractors for …

Cardinal Health (NYSE:CAH) Issues Quarterly Earnings Results, Beats Expectations By $0.49 EPS

Why Cardinal Health Stock Is Heading for a Record After Mixed Earnings

Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds. Continue Reading

Cardinal Health Stock Hits 52-Week High - Here's Why - Cardinal Health (NYSE:CAH)

Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Cardinal Health (CAH) reported revenue of $63.67 billion, up 5.8% over the same period last year. EPS came in at $2.91, compared to $2.08 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Cardinal Health Sales Miss; Rival McKesson Near Buy Point